CLEW, a clinical intelligence and predictive surveillance company, announced the general availability of its FDA-cleared, AI-driven, intelligent clinical surveillance platform. Built upon proprietary, machine-learning derived prediction models and rules-based best practices, the CLEW platform offers health systems an early identification of a patient’s risk of deterioration.
4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technology™, announced that it received regulatory clearance to market the newest addition to the company's anterior lumbar implant portfolio, the Anterior Spine Truss System with Anchor Fixation (ASTS-AF).
Universal Robots (UR), the world’s leading collaborative robot (cobot) company, has now integrated the Standard Robot Command Interface (SRCI) into its software. UR is proud to be among the first cobot vendors to offer this functionality.
Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced achievement of record revenue in the first quarter of 2024—outperforming Q4 2023, its previous record quarter.
Agitated Solutions, Incorporated (ASI) announced that it has been issued a Medical Device Establishment License (MDEL) from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.
Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, announced the U.S.
Medline, a market-leading manufacturer and supplier of medical supplies and solutions, is pleased to announce that it is now a direct distributor for Epredia, a member of PHC Group.
Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—announced that the first patients have been enrolled in the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) observational study.
Omnicell, Inc. a leader in transforming the pharmacy care delivery model, announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
Babson Diagnostics, a science-first healthcare technology company,announced the newest innovation in its BetterWay™ blood testing ecosystem has completed validation testing. The company created a unique hand-warming technology specifically designed to support the collection of high-quality blood samples from a fingertip.